Form D · Biotechnology

Pediatric Bioscience, Inc.

San Diego, CA · CIK 0001594462

Offering snapshot reported Mar 17, 2015 · SEC filing

Reported sold: $1.68M
Investors reported: 43
Minimum accepted: $0
First sale: Dec 1, 2014

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$670,921 → $1,677,288
Reported investors18 → 43

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 17, 2015	Amendment	$1,677,288	$1,006,367vs Dec 15, 2014	43	SEC filing
Dec 15, 2014	Initial	$670,921	No comparison	18	SEC filing
Jul 16, 2014	Amendment	$766,837	$0vs Jan 8, 2014	24	SEC filing
Jan 8, 2014	Initial	$766,837	No comparison	24	SEC filing
Dec 18, 2013	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-230147

Source: Form D, filed Mar 17, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Reo Carr	Director
Janelle M. D'alvise	Director, Executive
Jeff Friedman	Director
Matthew B. Friesen	Director
Charles R. Gardner, Jr.	Director
Sergio V. Gurrieri	Director
Linda P. O'keefe	Director, Executive
Winnie H. Wan	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

10581 Roselle Street Suite 115
San Diego, CA, 92121